Merck & Co., Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Merck & Co., Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 1.43M shares, a 44.67% decline from fiscal 2024.
- Merck & Co., Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 2.58M shares, a 33.45% increase from fiscal 2023.
- Merck & Co., Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 1.93M shares, a 69.38% decline from fiscal 2022.
- Merck & Co., Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 6.32M shares, a 69.45% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2025-12-31 | 1.43M shares 10-K · filed 2026-02-24 | |
| 2024-12-31 | 2.58M shares 10-K · filed 2025-02-25 | |
| 2023-12-31 | 1.93M shares 10-K · filed 2024-02-26 | |
| 2022-12-31 | 6.32M shares 10-K · filed 2023-02-24 | |
| 2021-12-31 | 3.73M shares 10-K · filed 2022-02-25 | |
| 2020-12-31 | 1.69M shares 10-K · filed 2021-02-25 | |
| 2019-12-31 | 8.12M shares 10-K · filed 2020-02-26 | |
| 2018-12-31 | 14.60M shares 10-K · filed 2019-02-27 | |
| 2017-12-31 | 11.51M shares 10-K · filed 2018-02-27 | |
| 2016-12-31 | 23.85M shares 10-K · filed 2017-02-28 | |
| 2015-12-31 | 13.78M shares 10-K · filed 2016-02-26 | |
| 2014-12-31 | 39.29M shares 10-K · filed 2015-02-27 | |
| 2013-12-31 | 33.28M shares 10-K · filed 2014-02-27 | |
| 2012-12-31 | 44.18M shares 10-K · filed 2013-02-28 | |
| 2011-12-31 | 12.44M shares 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |